IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Clinical Progress on IHL-216A for TBI and CTE, page-22

  1. 1,869 Posts.
    lightbulb Created with Sketch. 1472
    Bit off topic but seems BOT will get their Phase 2 Dermatitis results out very soon.

    Interested to see how the market will react to that, as bearish as it is right now.

    Good results and market sentiment for them will bode well for us with our OSA+TBI trials IMO.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.